secwatch.observer — SEC 8-K summary
======================================

Issuer:     MeiraGTx Holdings plc (MGTX)
CIK:        0001735438
Form:       8-K
Filed at:   2022-04-27T23:59:59+00:00
Accession:  0001558370-22-006046
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MeiraGTx appoints Debra Yu, MD to Board of Directors
----------------------------------------------------

- Dr. Yu appointed effective April 25, 2022 as Class II director; term expires at 2023 annual meeting.
- Recommended by largest shareholder Perceptive Advisors and senior management.
- Currently President and Chief Strategy Officer of LianBio; over 30 years healthcare industry experience.
- Previously held senior positions at Pfizer, Labrador Advisors, and two life science VC firms.
- Eligible for compensation under Company's Non-Employee Director Compensation Program.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1735438/000155837022006046/0001558370-22-006046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1735438/000155837022006046/mgtx-20220425x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-006046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer